BIOMARIN PHARMACEUTICAL INC

CUSIP: 09061GAH4 Class: Convertible Debt

MORGAN STANLEY's Holding History (CIK: 0000895421)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024
Shares 2,065,000 Value ($000) $2,048 Avg Close — Range —
Q1 2024
Shares 2,294,000 Value ($000) $2,252 Avg Close — Range —
Q4 2023
Shares 3,524,000 Value ($000) $3,473 Avg Close — Range —
Q3 2023
Shares 13,779,000 Value ($000) $13,314 Avg Close — Range —
Q2 2023
Shares 14,870,000 Value ($000) $14,628 Avg Close — Range —
Q1 2023
Shares 21,156,000 Value ($000) $21,706 Avg Close — Range —
Q4 2022
Shares 20,679,000 Value ($000) $22,030 Avg Close — Range —
Q3 2022
Shares 17,761,000 Value ($000) $17,732 Avg Close — Range —
Q2 2022
Shares 17,944,000 Value ($000) $17,747 Avg Close — Range —
Q1 2022
Shares 19,257,000 Value ($000) $19,110 Avg Close — Range —
Q4 2021
Shares 20,132,000 Value ($000) $21,050 Avg Close — Range —
Q3 2021
Shares 25,654,000 Value ($000) $26,282 Avg Close — Range —
Q2 2021
Shares 25,992,000 Value ($000) $26,899 Avg Close — Range —
Q1 2021
Shares 25,551,000 Value ($000) $26,089 Avg Close — Range —
Q4 2020
Shares 27,042,000 Value ($000) $28,684 Avg Close — Range —
Q3 2020
Shares 23,942,000 Value ($000) $25,191 Avg Close — Range —
Q2 2020
Shares 20,430,000 Value ($000) $24,974 Avg Close — Range —
Q1 2020
Shares 19,123,000 Value ($000) $19,815 Avg Close — Range —
Q4 2019
Shares 3,907,000 Value ($000) $4,085 Avg Close — Range —
Q3 2019
Shares 4,518,000 Value ($000) $4,408 Avg Close — Range —
Q2 2019
Shares 5,363,000 Value ($000) $5,547 Avg Close — Range —
Q1 2019
Shares 3,002,000 Value ($000) $3,072 Avg Close — Range —
Q4 2018
Shares 4,197,000 Value ($000) $4,172 Avg Close — Range —
Q3 2018
Shares 4,180,000 Value ($000) $4,395 Avg Close — Range —
Q2 2018
Shares 6,409,000 Value ($000) $6,511 Avg Close — Range —
Q1 2018
Shares 4,189,000 Value ($000) $3,936 Avg Close — Range —
Q4 2017
Shares 6,427,000 Value ($000) $6,369 Avg Close — Range —